Cardinal Health (NYSE: CAH) has seen an increase in its stock price target, with several analysts recognizing its strong financial performance. Argus raised its price target from $211.00 to $232.00, maintaining a buy rating on the stock, according to a report issued on Friday. This follows a series of positive adjustments from other financial institutions.
On January 15, Wells Fargo & Company revised its target for Cardinal Health from $221.00 to $237.00, labeling the stock as “overweight.” Similarly, TD Cowen increased its target from $183.00 to $225.00 and also assigned a buy rating. Mizuho set a price target of $222.00 on January 12, while Robert W. Baird established a target of $250.00 on January 14. Currently, fourteen analysts have rated the stock as a buy, while two have given it a hold rating. According to MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $221.07.
The firm recently reported its earnings for the quarter ending October 30, 2025, revealing significant growth. Cardinal Health posted earnings of $2.55 per share, surpassing analysts’ expectations of $2.22 by $0.33. The company generated revenues of $64.01 billion, well above the anticipated $59.41 billion. This marks a year-over-year revenue increase of 22.4%. In the same quarter last year, the company reported earnings of $1.88 per share.
In light of these results, Cardinal Health has projected its fiscal year 2026 earnings per share guidance to be between $9.650 and $9.850. Analysts expect the company to achieve an average of $7.95 in earnings per share for the current fiscal year.
Dividend Announcement and Investor Activity
In addition to its robust earnings, Cardinal Health recently declared a quarterly dividend of $0.5107, which was paid on January 15, 2025, to stockholders of record as of January 2. This dividend represents an annualized payout of $2.04 and a dividend yield of 1.0%. The company’s payout ratio stands at 30.77%.
Institutional investors have also shown increased interest in Cardinal Health. Redhawk Wealth Advisors Inc. elevated its holdings in the company by 0.5% during the fourth quarter, now owning 9,255 shares valued at approximately $1.9 million. HF Advisory Group LLC raised its position by 0.9%, while Latitude Advisors LLC increased its stake by 2.1%. Overall, institutional investors hold 87.17% of Cardinal Health’s stock.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health is a prominent player in the healthcare sector, providing a range of services and products. Established in the early 1970s, the company has become a key provider of supply chain and distribution services for healthcare institutions, including hospitals, pharmacies, and clinical laboratories. Its core operations encompass the wholesale distribution of both branded and generic pharmaceuticals, as well as medical-surgical products and logistics solutions.
As Cardinal Health continues to perform strongly in the market, analysts and investors alike are closely monitoring its trajectory, especially in light of its recent financial results and strategic initiatives.
